The IUCPQ Triton platform is dedicated to supporting research teams in the development and optimization of high-quality immunohistochemistry (IHC) assays using state-of-the-art equipment. Led by Dr. Philippe Joubert, a board-certified anatomopathologist, the platform benefits from the expertise of two experienced professionals: Sophie Plante, platform coordinator, and Michèle Orain, technical advisor.

Together, this team offers comprehensive guidance throughout the assay development process—from initial design to validation—ensuring that each step meets rigorous quality standards for reliable and reproducible results.

The IUCPQ Biobank is a cutting-edge research platform that supports translational studies by providing access to a vast and well-characterized collection of biological specimens and associated data. With over 44,000 specimens from 6,480 cancer patients, including resection samples, liquid biopsies, and immunotherapy cases, the biobank is a cornerstone for lung cancer research.

Under rigorous quality standards, the biobank integrates clinical (120 variables), pathological, radiological (6,480 CT scans), and molecular data—including mutational profiles (Oncomine, genotypes), transcriptional data (RNAseq), and spatial analyses (CYTOF, Visium, Akoya, IHC). It also supports advanced metabolomic profiling via LC-MS.

This comprehensive resource enables researchers to conduct high-impact studies in biomarker discovery, precision medicine, and integrative pathology, accelerating the translation of scientific findings into clinical applications.